Treatment of obesity, diabetes and other symptoms of hypercorticoidism using etiocholanolones
US4666898A · kind A · utility
21Cited by
2References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 19, 1984 |
| Grant date | May 19, 1987 |
| Priority date | — |
| Expiry date | Dec 19, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Obesity, diabetes obesity syndromes and associated hypercorticoidism are treated with .alpha. and/or .beta.-etiocholanolone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.